Published in Respiratory Therapeutics Week, October 3rd, 2005
According to recent research from the United States, "Chemotherapy of tuberculosis caused by multiple-drug-resistant (MDR) strains is problematic because of choices limited to relatively inefficacious and toxic drugs."
"Some beta-lactam antibiotics are active against Mycobacterium tuberculosis in vitro. We investigated the efficacy of imipenem in a mouse model of tuberculosis and in humans with MDR tuberculosis," explained scientists.
"Mice infected with M. tuberculosis strain H37Rv were treated with isoniazid or imipenem....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Respiratory Therapeutics Week